Case Selection During the COVID-19 Pandemic: Who Should Go to the Cardiac Catheterization Laboratory?

Evangelia Vemmou1, Ilias Nikolakopoulos1, Emmanouil S Brilakis1

  • 1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, 920 E 28th Street #300, Minneapolis, MN 55407 USA.

Insights

The COVID-19 pandemic significantly reduced cardiac catheterization laboratory (CCL) use for ST-elevation myocardial infarction (STEMI) care, increasing morbidity and mortality. Balancing patient needs with healthcare worker safety remains a critical challenge.

Area of Science:

  • Cardiology
  • Infectious Disease Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic necessitated restructuring of cardiovascular services globally.
  • This restructuring aimed to preserve hospital resources like beds and personal protective equipment.
  • Unintended consequences significantly impacted healthcare delivery and patient outcomes.

Purpose of the Study:

  • To review evidence and recommendations for selecting ST-elevation myocardial infarction (STEMI) cases for cardiac catheterization laboratory (CCL) procedures during the COVID-19 pandemic.
  • To emphasize management strategies for STEMI during the pandemic.
  • To provide guidance on balancing patient care with infection risk.

Main Methods:

  • Systematic review of available evidence.
  • Analysis of recommendations from consensus documents.
  • Synthesis of findings on case selection and management.

Main Results:

  • A significant reduction in CCL activations for STEMI was observed in the US (38%).
  • Utilization of invasive angiography decreased by 34%, and primary percutaneous coronary intervention (PPCI) by 18%.
  • Door-to-balloon times increased by 19%, coinciding with more out-of-hospital cardiac arrests and late STEMI presentations. A shift to pharmacological reperfusion in Asia led to increased morbidity and mortality.

Conclusions:

  • COVID-19 negatively impacted STEMI care, particularly timely mechanical reperfusion, leading to increased morbidity and mortality.
  • Balancing optimal STEMI care with infection risk for healthcare workers is a significant challenge.
  • Consensus recommendations offer valuable guidance for navigating these complexities.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
436
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
337
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
369
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
321
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
78
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
110